Replies to post #45237 on RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

Hard to say. It is all speculation at this point.

All we can go off of is the CEO's recent interview a few months ago which expressed confidence in their drug candidate KRM-II-81 that is in tier 3 NIH preclinicals. There he suggested they would get grant money into human clinicals assuming the addicitive liability in the preclinicals is a positive progression. He also suggested they are looking for funding "pursestrings" support for the development, which can take many different shapes, but IMO something as significant as getting greenlighted into human clincals to mitigate the opioid crisis is big time and requires BP support if not fully taking the baton on the program. If that happens we likely are trading by nickels and dimes...Again all speculation but why else to invest in the OTC? Risk v. Reward

They claimed in PR to be waiting for funding for the ADHD/SCI drug candidate and the OSA program is in Australia and assuming waiting for preclincal work to complete, but again no recent update there either.